Monday, March 27, 2023

In addition to our commitment to raising the starkly low survival rate of pancreatic cancer, we are also dedicated to supporting Canadians through every stage of this disease; including death. Our CEO, Michelle Capobianco spoke with Health Insight for their ‘Advancements in Cancer Care’ issue, to share how PCC is leading important end of life conversations through patient support and advocacy.